Cargando…
Predicting treatment response to IL6R blockers in rheumatoid arthritis
Patients with severe, active RA who have not responded to conventional therapy may receive biological disease modifying anti-rheumatic drugs (bDMARDs). However, 40% of cases do not achieve complete disease control, resulting in a negative impact on patient quality of life and representing a waste of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733712/ https://www.ncbi.nlm.nih.gov/pubmed/32864695 http://dx.doi.org/10.1093/rheumatology/keaa529 |